{"entity":{"id":"nct06427460","kind":"trial","name":"Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)","aka":[],"tldr":"A phase 2 trial in pancreatic cancer, run by Changhai Hospital, now recruiting.","summary":"Central-boost Ablative Radiation Therapy for Solid Tumors (CBART) is a phase 2, interventional study registered as NCT06427460 by Changhai Hospital, with a registry enrolment figure of 67 participants, started 2024-05-12 and due to reach its primary completion in 2025-06-30. Interventions recorded: Central-boost ablative dose delivered by stereotactic body radiation therapy. Conditions listed: Pancreatic Cancer. Primary outcome: One-year local control will be determined.. Pancreatic eligibility wording from the registry: \"* Pathologically confirmed lung, liver, pancreas or retroperitoneal malignant tumor\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06427460","url":"https://clinicaltrials.gov/study/NCT06427460"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["pancreatic"],"sections":[],"technologies":["sbrt"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06427460","phase":"2","setting":"Central-boost Ablative Radiation Therapy for Large Tumors or Tumors Adjacent to Organs at Risk","sponsor":"Changhai Hospital","enrolled":67,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06427460/","neighbours":{"cancer":[{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}],"technology":[{"id":"sbrt","kind":"technology","name":"SBRT / SABR (stereotactic radiotherapy)","route":"/technologies/sbrt/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}